Annotation: Principles of treatment for hyperkinetic disorder: Practice approaches for the U.K.

Journal of Child Psychology and Psychiatry and Allied Disciplines

Volumn 40, Issue 8, 1999, Pages 1147-1157

  Overmeyer, Stephen ^a   Taylor, Eric ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

ADD ADHD; Attention; Hyperactivity; Methylphenidate; Psychiatric practice; Therapy

Indexed keywords

CLONIDINE; DESIPRAMINE; DEXAMPHETAMINE; HALOPERIDOL; IMIPRAMINE; METHYLPHENIDATE; PEMOLINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADOLESCENT; ANOREXIA; ATTENTION DEFICIT DISORDER; AUTISM; BEHAVIOR THERAPY; CHILD; COGNITIVE THERAPY; DIET; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG SAFETY; DYSPHORIA; DYSTONIA; EPILEPSY; GASTROINTESTINAL SYMPTOM; HEADACHE; HEALTH CARE DELIVERY; HUMAN; HYPERKINESIA; INSOMNIA; LEARNING DISORDER; LIVER DYSFUNCTION; REVIEW; TACHYCARDIA; TIC; UNITED KINGDOM;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BEHAVIOR THERAPY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DIAGNOSIS, DIFFERENTIAL; HUMANS; PSYCHIATRIC STATUS RATING SCALES; TREATMENT OUTCOME;

EID: 0032731509     PISSN: 00219630     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0021963099004758     Document Type: Review

References (101)

1. Abikoff, H., & Klein, R. G. (1992). Attention-deficit hyperactivity and conduct disorder: Comorbidity and implications for treatment. Journal of Consulting and Clinical Psychology, 60, 881-892.
2. Ahmann, P. A., Waltonen, S. J., Olson, A., Theye, F. W., Van Erem, A. J., & LaPlant, R. J. (1993). Placebo-controlled evaluation of ritalin side effects. Journal of Pediatrics, 91, 1101-1106.
3. Aman, M. G., Marks, R. E., Turbott, S. H., Wilsher, C. P., & Merry, S. N. (1991). Clinical effects of methylphenidate and thioridazine in intellectually subaverage children. Journal of the American Academy of Child and Adolescent Psychiatry, 30, 246-256.
4. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
5. Barkley, R. A. (1985). The social behaviour of hyperactive children: Developmental changes, drug effects, and situational variation. In R. McMahon & R. Teters (Eds.), Childhood disorders (pp. 218-243). New York: Brunner/ Mazel.
6. Barkley, R. A. (1988). The effects of methylphenidate on the interactions of preschool ADHD children with their mothers. Journal of the American Academy of Child and Adolescent Psychiatry, 27, 336-341.
7. Barkley, R. A. (1990). Attention deficit hyperactivity disorder: A handbook for diagnosis and treatment. New York: Guilford Press.
8. Barkley, R. A., DuPaul, G. J., & McMurray, M. B. (1991). Attention deficit disorder with and without hyperactivity: Clinical response to three dose levels of methylphenidate. Pediatrics, 87, 519-531.
9. Barkley, R. A., Fischer, M., Edelbrock, C. S., & Smallish, L. (1991). The adolescent outcome of hyperactive children diagnosed by research criteria - III. Mother-child interactions, family conflicts and maternal psychopathology. Journal of Child Psychology and Psychiatry, 32, 233-255.
10. Barkley, R. A., Karlsson, J., Strzeletcki, E., & Murphy, J. (1984). Effects of age and ritalin dosage on the mother-child interactions of hyperactive children. Journal of Consulting and Clinical Psychology, 52, 750-758.
11. Barkley, R. A., McMurray, M. B., Edelbrock, C. S., & Robbins, K. (1989). The response of aggressive and nonaggressive ADHD children to two doses of methylphenidate. Journal of the American Academy of Child and Adolescent Psychiatry, 28, 873-881.
12. Barkley, R. A., McMurray, M. B., Edelbrock, C. S., & Robbins, K. (1990). Side effects of methylphenidate in children with attention deficit hyperactivity disorder: A systemic, placebo-controlled evaluation. Pediatrics, 86, 184-192.
13. Berkovitch, M., Pope, E., Phillips, J., & Koren, G. (1995). Pemoline-associated fulminant liver failure: Testing the evidence for causation. Clinical Pharmacological Therapy, 577, 696-698.
14. Birmaher, B., Quintana, H., & Greenhill, L. L. (1988). Methylphenidate treatment of hyperactive autistic children. Journal of the American Academy of Child and Adolescent Psychiatry, 27, 248-251.
15. Bravidor, C., Wetzel, K., & John, K. (1990). Prognostic value of hyperkinetic syndrome in children with epilepsy. Kinderärztliche Praxis, 58, 261-266.
16. Brown, C. S. (1991). Treatment of attention deficit hyperactivity disorder: A critical review. Developments in Child Psychology, 25, 1207-1213.
17. Brown, R. T., Wynne, M., Borden, K. A., Clingerman, R., Geniesse, R., & Spunt, A. L. (1986). Methylphenidate and cognitive therapy in children with attention deficit disorder: A double-blind trial. Development and Behavior in Pediatrics, 7, 163-170.
18. Buhrmester, D., Whalen, C. K., Henker, B., McDonald, V., & Hinshaw, S. P. (1992). Prosocial behavior in hyperactive boys: Effects of stimulant medication and comparison with normal boys. Journal of Abnormal Child Psychology, 20, 103-121.
19. Buitelaar, J. K., Van der Gaag, R. J., Swaab-Barneveld, H., & Kuiper, M. (1995). Prediction of clinical response to methylphenidate in children with attention-deficit hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 1025-1032.
20. Calis, K. A., Grothe, D. R., & Elia, J. (1990). Attention deficit hyperactivity disorder. Clinical Pharmacology, 9, 632-642.
21. Carlson, C. L., Pelham, W. E., Milich, R., & Dixon, J. (1992). Single and combined effects of methylphenidate and behaviour therapy on the classroom performance of children with Attention-Deficit Hyperactivity Disorder. Journal of Abnormal Child Psychology, 20, 213-232.
22. Carter, C. M., Urbanowicz, M., Hemsley, R., Mantilla, L., Strobel, S., Graham, P. J., & Taylor, E. (1993). Effects of a few food diet in attention deficit disorder. Archives of Disease in Childhood, 69, 564-568.
23. Charles, L., & Scham, R. J. (1981). A 4-year follow-up study of the effects of methylphenidate on the behavior and academic achievement of hyperactive children. Journal of Abnormal Child Psychology. 9, 495-505.
24. Conners, C. K. (1995). The Conners Rating Scales: Instruments for the assessment of childhood psychopathology. North Tonawanda, NY: Multi-Health System.
25. Conners, C. K., & Taylor, E. (1980). Pemoline, methylphenidate, and placebo in children with minimal brain dysfunction. Archives of General Psychiatry, 37, 922-930.
26. Cunningham, C. E., Bremner, R., & Boyle, M. (1995). Large group community-based parenting programs for families of preschoolers at risk for disruptive behavior disorders: Utilization, cost effectiveness, and outcome. Journal of Child Psychology and Psychiatry, 36, 1141-1159.
27. De Quiros, G. B., Kinsbourne, M., Palmer, R., & Tocci Rufo, D. (1994). Attention deficit disorder in children: Three clinical variants. Journal of Developmental and Behavioural Pediatrics, 15, 311-319.
28. Dodge, K. A. (1986). A social information processing model of social competence in children. In M. Perlmutter (Ed.), The Minnesota Symposia on Child Psychology, Vol. 18. Cognitive perspectives on children's social and behavioral development (pp. 77-125). Hillsdale, NJ: Lawrence Erlbaum.
29. Douglas, V. I. (1980). Treatment and training approaches to hyperactivity: Establishing internal and external control. In C. K. Whalen & B. Henker (Eds.), Hyperactive children: The social ecology of identification and treatment (pp. 283-317). New York: Academic Press.
30. Douglas, V. I., Barr, R. G., Amin, K., O'Neill, M. E., & Britton, B. G. (1988). Dosage effects and individual responsivity to methylphenidate in attention deficit disorder. Journal of Child Psychology and Psychiatry, 29, 453-475.
31. DuPaul, G. J., & Stoner, G. (1994). ADHD in the schools. Assessment and intervention strategies. New York: Guilford Press.
32. Egger, J., Carter, C. M., Graham, P. J., Gumley, D., & Soothill, J. F. (1985). Controlled trial of oligoantigenic treatment in the hyperkinetic syndrome. Lancet, i, 540-545.
33. Elia, J., Borcherding, B. G., Rapoport, J. L., & Keysor, C. (1991). Methylphenidate and dextroamphetamine treatments of hyperactivity; are there true nonresponders? Psychiatry Research, 36, 141-155.
34. Famularo, R., & Fenton, T. (1987). The effect of methylphenidate on school grades in children with attention deficit disorder without hyperactivity: A preliminary study. Journal of Clinical Psychiatry, 48, 112-114.
35. Feingold, B. F. (1975). Hyperkinesis and learning disabilities linked to artificial food flavors and colors. American Journal of Nursing, 75, 797-803.
36. Feldman, H., Crumrine, P., Handen, B. L., Alvin, R., & Teodori, J. (1989). Methylphenidate in children with seizures and attention-deficit disorder. American Journal of Diseases in Childhood, 143, 1081-1086.
37. Gadow, K. D. (1985). Prevalence and efficacy of stimulant drug use with mentally retarded children and youth. Psychopharmacology Bulletin, 21, 291-303.
38. Gillberg, C., Melander, H., von Knorring, A.-L., Janols, L.-O., Thernlund, G., Haeggloef, B., Eideval-Wallin, L., Gustaffson, P., & Kopp, S. (1997). Long-term stimulant treatment of children with Attention-deficit hyperactivity disorder symptoms: A randomized, double-blind, placebo-controlled trial. Archives of General Psychiatry, 54, 857-864.
39. Gittelman-Klein, R. (1980). Indications for the use of stimulant treatment in learning disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 19, 623-636.
40. Gittelman-Klein, R., & Abikoff, H. (1989). The role of psychostimulants and psychosocial treatments in hyperkinesis. In T. Sagvolden & T. Archer (Eds.), Attention deficit disorder. Clinical and basic research (pp. 167-180). Hillsdale, NJ: Lawrence Erlbaum.
41. Greenhill, L. L., & Setterberg, S. (1993). Pharmacotherapy of disorders of adolescents. Psychiatry Clinics of North America, 16, 793-814.
42. Gross-Tsur, V., Manor, O., van der Meere, J., Joseph, A., & Shalev, R. S. (1997). Epilepsy and attention deficit hyperactivity disorder: Is methylphenidate safe and effective? Journal of Pediatrics, 130, 40-44.
43. Handen, B. L., Breaux, A. M., Janovsky, J., McAuliffe, S., Feldman, H., & Gosling, A. (1992). Effects and noneffects of methylphenidate in children with mental retardation and ADHD. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 455-461.
44. Handen, B. L., Janovsky, J., Gosling, A., Breaux, A. M., & McAuliffe, S. (1991). Adverse side effects of methylphenidate among mentally retarded children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry, 30, 241-245.
45. Herbert, M. (1994). Behavioural methods. In M. Rutter, E. Taylor, & L. Hersov (Eds.), Child and adolescent psychiatry: Modern approaches (3rd ed., pp. 858-879). Oxford: Blackwell Scientific Publications.
46. Ho, T. P., Luk, E. S. L., Taylor, E., Mak, F. L., & Bacon-Shone, J. (1996). Situational versus pervasive hyperactivity in a community sample. Psychological Medicine, 26, 309-321.
47. Hogg, J. (1992). The administration of psychotropic and anticonvulsant drugs to children with profound intellectual disability and multiple impairments. Journal of Intellectual and Disability Research, 36, 473-488.
48. Horn, W. F., Ialongo, N. S., Pascoe, J. M., Greenberg, G., Packard, T., Lopez, M., Wagner, A., & Puttler, L. (1991). Additive effects of psychostimulants, parent training, and self-control therapy with ADHD children. Journal of the American Academy of Child and Adolescent Psychiatry, 30, 233-240.
49. Hunt, R. D., Minderaa, R. B., & Cohen, D. J. (1985). Clonidine benefits children with attention deficit disorder and hyperactivity: Report of a double-blind placebo-crossover therapeutic trial. Journal of the American Academy of Child Psychiatry, 24, 617-629.
50. Johnston, C., & Fine, S. (1993). Methods of evaluating methylphenidate in children with attention deficit hyperactivity disorder: Acceptability, satisfaction, and compliance. Journal of Pediatric Psychology, 18, 717-730.
51. Kaplan, B. J., McNicol, J., Conte, R. A., & Moghadam, H. K. (1989). Dietary replacement in preschool-aged hyperactive boys. Pediatrics, 83, 7-17.
52. Kazdin, A., Bass, D., Siegel, T., & Thomas, C. (1989). Cognitive-behavioral and relationship therapy in the treatment of children referred for antisocial behavior. Journal of Consulting and Clinical Psychology, 57, 522-535.
53. Kazdin, A., Sveldt-Dawson, K., French, N., & Unis, A. (1987). Effects of parent management training and problem-solving skills training combined in the treatment of antisocial child behavior. Journal of the American Academy of Child and Adolescent Psychiatry, 26, 416-424.
54. Kendall, P. C., & Braswell, L. (1993). Cognitive-behavioral therapy for impulsive children (2nd ed.). New York: Guilford Press.
55. Kendall, P. C., & Panichelli-Mindel, S. M. (1995). Cognitive-behavioural treatments. Journal of Abnormal Child Psychology, 23, 107-124.
56. Kinney, R. O., Shaywitz, B. A., Shaywitz, S. E., Sarwar, M., & Holohan, J. M. (1990). Epilepsy in children with attention deficit disorder: Cognitive, behavioral, and neuroanatomic indices. Pediatric Neurology, 6, 31-37.
57. Klein, R. G., & Mannuzza, S. (1988). Hyperactive boys almost grown up: III. Methylphenidate effects on ultimate height. Archives of General Psychiatry, 45, 1131-1134.
58. Leonard, H. L., Meyer, M. C., Swedo, S. E., Richter, D., Hamburger, S. D., Allen, A. J., Rapoport, J. L., & Tucker, E. (1995). Electrocardiographic changes during desipramine and clomipramine treatment in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 1460-1468.
59. Levy, F. (1993). Side effects of stimulant use. Journal of Paediatric Child Health, 29, 250-254.
60. Lochman, J. E., White, K. J. & Wayland, K. K. (1991). Cognitive-behavioral assessment and treatment with aggressive children. In P. C. Kendall (Ed.) Child and adolescent therapy: Cognitive-behavioral procedures (pp. 25-65). New York: Guilford Press.
61. Matier, K., Halperin, J. M., Sharma, V., Newcorn, J. H., & Sthaye, N. (1992). Methylphenidate response in aggressive and nonaggressive ADHD children: Distinctions on laboratory measures of symptoms. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 219-225.
62. Mattes, J. A., & Gittelman, R. (1981). Effects of artificial food colorings in children with hyperactive symptoms. Archives of General Psychiatry, 38, 714-718.
63. Mayes, S. D., Crites, L., Bixler, E. O., Humphrey, F. J. II, & Mattison, E. (1994). Methylphenidate and ADHD: Influence of age, IQ and neurodevelopmental status. Developmental Medicine and Child Neurology, 36, 1099-1107.
64. Nehra, A., Mullick, F., Ishak, K. G., & Zimmerman, H. J. (1990). Pemoline-associated hepatic injury. Gastroenterology, 99, 1517-1519.
65. Pelham, W. E., Bender, M. E., Caddell, J., Booth, S., & Moorer, S. (1985). The dose-response effects of methylphenidate on classroom academic and social behavior in children with attention deficit disorder. Archives of General Psychiatry, 42, 948-952.
66. Pelham, W. E., Carlson, C., Sams, S. E., Vallano, G., Dixon, M. J., & Hoza, B. (1993). Separate and combined effects of methylphenidate and behavior modification on boys with attention deficit-hyperactivity disorder in the classroom. Journal of Consulting and Clinical Psychology, 61, 506-515.
67. Pelham, W. E., & Hinshaw, S. (1992). Behavioral intervention for attention deficit disorder. In S. M. Turner, K. S. Calhorn, & H. E. Adams (Eds.), Handbook of clinical behavior therapy. Vol. 2 (pp. 259-283). New York: Wiley.
68. Pelham, W. E., Swanson, J. M., Furman, M. B., & Schwindt, H. (1995). Pemoline effects on children with ADHD: A time-response by dose-response analysis on classroom measures. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 1504-1514.
69. Pliszka, S. R. (1989). Effect of anxiety on cognition, behavior, and stimulant response in ADHD. Journal of the Academy of Child and Adolescent Psychiatry, 28, 882-887.
70. Quintana, H., Birmaher, B., Stedge, D., Lennon, S., Reed, J., Bridge, J., & Greenhill, L. (1995). Use of methylphenidate in the treatment of children with autistic disorder. Journal of Autism and Developmental Disorder, 25, 283-294.
71. Rapoport, J., Buchsbaum, M., Weingartner, H., Zahn, T., Ludlow, C., & Mikkelsen, M. (1978). Dextroamphetamine: Behavioral and cognitive effects in normal prepubertal boys. Science, 199, 560-563.
72. Robertson, M. N., & Eapen, V. (1992). Pharmacologic controversy of CNS stimulants in Gilles de la Tourette's Syndrome. Clinical Neuropharmacology, 15, 408-425.
73. Roche, A., Lipman, R., Overall, J., & Hung, W. (1979). The effects of stimulant medication on the growth of hyperkinetic children. Pediatrics, 63, 847-850.
74. Satterfield, J. H., Satterfield, B. T., & Schell, A. M. (1987). Therapeutic interventions to prevent delinquency in hyperactive boys. Journal of the American Academy of Child and Adolescent Psychiatry, 26, 56-64.
75. Schachar, R., Tannock, R., & Logan, G. (1993). Inhibitory control, impulsiveness, and attention deficit hyperactivity disorder. Clinical Psychology Review, 13, 721-739.
76. Schachar, R., Tannock, R., Marriott, M., & Logan, G. (1995). Deficient inhibitory control in attention deficit hyperactivity disorder. Journal of Abnormal Child Psychology, 23, 411-437.
77. Schulte-Korne, G., Deimel, W., Gutenbrunner, C., Henninghausen, K., Blank, R., Rieger, C., & Remschmidt, H. (1996). Effect of an oligoantigen diet on the behaviour of hyperkinetic children. Zeitschrift fur Kinder- und Jugenpsvchiatrie, 24, 176-183.
78. Sergeant, J., & Steinhausen, H. C. (1992). European perspectives on hyperkinetic disorder. European Journal of Child Psychiatry, 1, 34-41.
79. Shapiro, A. K., & Shapiro, E. (1982). Clinical efficacy of haloperidol, pimozide, penfluridol and clonidine in the treatment of Tourette syndrome. Advances in Neurology, 35, 383-386.
80. Singer, H. S., Brown, J., Quaskey, S., Rosenberg, L. A., Mellits, E. D., & Denckla, M. B. (1995). The treatment of attention deficit hyperactivity disorder in Tourette's syndrome: A double-blind placebo-controlled study with clonidine and desipramine. Pediatrics, 95, 74-81.
81. Sleator, E., Neumann, H., & Sprague, R. (1974). Hyperactive children: A continuous long-term placebo-controlled follow-up. Journal of the American Medical Association, 229, 316-317.
82. Spencer, T., Biederman, J., Kerman, K., Steingard, R., & Wilems, T. (1993). Desipramine treatment of children with attention-deficit hyperactivity disorder and tic disorder or Tourette's syndrome. Journal of the American Academy of Child and Adolescent Psychiatry, 32, 354-360.
83. Stayhorn, J. M., Jr., Rapp, N., Donina, W., & Strain, P. S. (1988). Randomized trial of methylphenidate for an autistic child. Journal of the American Academy of Child and Adolescent Psychiatry, 27, 244-247.
84. Swanson, J. M., McBurnett, K., Wigal, T., Pfiffner, L. J., Lerner, M. A., Williams, L., Christian, D. L., Tamm, L., Willcutt, E., Crowley, K., Clevenger, W., Khouzam, N., Woo, C., Crinella, F. M., & Fisher, T. D. (1993). Effect of stimulant medication on children with Attention Deficit Disorder: A "review of reviews". Exceptional Children, 60, 154-162.
85. Taylor, E. (1987). Cultural differences in hyperactivity. Advances in Developmental and Behavioral Pediatrics, 8, 125-150.
86. Taylor, E. (1994a). Physical treatments. In M. Rutter, E. Taylor, & L. Hersov (Eds.), Child and adolescent psychiatry: Modern approaches (3rd ed., pp. 880-899). Oxford: Blackwell Scientific Publications.
87. Taylor, E. (1994b). Syndromes of attention deficit and over-activity. In M. Rutter, E. Taylor, & L. Hersov (Eds.), Child and adolescent psychiatry: Modern approaches (3rd ed., pp. 285-307). Oxford: Blackwell Scientific Publications.
88. Taylor, E. (1995). Dysfunctions of attention. In D. Cicchetti & D. J. Cohen (Eds.), Developmental psychopathology, Vol. 2: Risk, disorder and adaptation (pp. 243-273). New York: John Wiley & Sons.
89. Taylor, E., Chadwick, O., Heptinstall, E., & Danckaerts, M. (1996). Hyperactivity and conduct problems as risk factors for adolescent development. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1213-1226.
90. Taylor, E., Sandberg, S., Thorley, G., & Giles, S. (1991). The epidemiology of childhood hyperactivity. Maudsley monographs. No. 33. Oxford: Oxford University Press.
91. Taylor, E., Schachar, R., Thorley, G., Wieselberg, H. M., Everitt, B., & Rutter, M. (1987). Which boys respond to stimulant medication? A controlled trial of methylphenidate in boys with disruptive behaviour. Psychological Medicine, 17, 121-143.
92. Taylor, E., Sergeant, J., Doefner, M., Gunning, B., Overmeyer, S., Mobius, H. J., & Eisert, H. (1998). Guidelines for treatment of hyperkinetic disorders. European Child and Adolescent Psychiatry, 7, 184-200.
93. Tirosh, E., Sadeh, A., Munvez, R., & Lavie, P. (1993). Effects of methylphenidate on sleep in children with attention-deficient hyperactivity disorder. An activity monitor study. American Journal of Diseases of Children, 147, 1313-1315.
94. Voelker, S. L., Lachar, D., & Gdowski, L. L. (1983). The personality inventory for children and response to methylphenidate: Preliminary evidence for predictive validity. Journal of Pediatric Psychology, 8, 161-169.
95. Werry, J. S., & Aman, M. G. (1993). Practitioner's guide to psychoactive drugs for children and adolescents. New York: Plenum Publishing Corporation.
96. Wolraich, M., Drummond, T., Salomon, M., O'Brien, M., & Sivage, C. (1978). Effects of methylphenidate alone and in combination with behavior modification procedures on the behavior and academic performance of hyperactive children. Journal of Abnormal Child Psychology, 6, 149-161.
97. Woodward, L., Dowdney, L., & Taylor, E. (1997). Child and family factors influencing the clinical referral of children with hyperactivity. Journal of Child Psychology and Psychiatry, 38, 479-485.
98. World Health Organisation. (1992). International classification of diseases (10th ed.). Geneva: WHO Division of Mental Health.
99. Wroblewski, B. A., Leary, J. M., Phelan, A. M., Whyte, J., & Manning, K. (1992). Methylphenidate and seizure frequency in brain injured patients with seizure disorders. Journal of Clinical Psychiatry, 53, 86-89.
100. Young, E., Patel, S., Stoneham, M., Rona, R., & Wilkinson, J. D. (1987). The prevalence of reaction to food additives in a survey population. Journal of the Royal College of Physicians of London, 21, 241-247.
101. Yule, W. (1986). Behavioural treatments. In E. Taylor (Ed.), The overactive child. Clinics in Developmental Medicine no. 97 (pp. 219-235). Oxford: MacKeith Press/Blackwell.